NHS Rolls Out ‘Game Changer’ Pilot Blood Test For Detecting Over 50 Types of Cancer

This June, Grail Inc., a biotechnology company, launched its Galleri blood test, designed to detect multiple cancers at an early stage from a single sample, for prescription use in the US.